Overview
DXCM market data
Price History
DXCM price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for DXCM. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
DexCom Selected As First Participant For FDA's TEMPO Digital Health Devices ProgramBenzinga · Jul 22, 2026, 9:18 PM
Dexcom Selected By FDA As First Participant For Technology-Enabled Meaningful Patient Outcomes For Digital Health Devices PilotBenzinga · Jul 22, 2026, 6:14 PM
DexCom shares are trading higher after Truist Securities raised its price target on the stock from $80 to $87.Benzinga · Jul 16, 2026, 6:51 PM
Truist Securities Maintains Buy on DexCom, Raises Price Target to $87Benzinga · Jul 16, 2026, 3:51 PM
Mizuho Maintains Outperform on DexCom, Raises Price Target to $90Benzinga · Jul 15, 2026, 6:23 PM
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market InsightsGlobenewswire Inc · Jul 14, 2026, 11:00 AM
Dexcom Receives Health Canada Authorization For Dexcom G7 15 Day CGM System, Offering 15.5-Day Wear, 8.0% MARD Accuracy, And Fewer Sensor Changes For Canadians With DiabetesBenzinga · Jul 13, 2026, 8:46 PM
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga · Jun 23, 2026, 1:50 PM
Deutsche Bank Initiates Coverage On DexCom with Buy Rating, Announces Price Target of $86Benzinga · Jun 23, 2026, 1:30 PM
Dexcom Scores Pediatric Expansion For OTC Stelo Glucose MonitorBenzinga · Jun 15, 2026, 6:15 PM